市場調查報告書
商品編碼
1465991
生命科學工具市場:按技術、產品、服務、實驗室所有者、實驗室規模、最終用戶分類 - 2024-2030 年全球預測Life Science Tools Market by Technology, Product, Offerings, Lab Ownership, Lab Size, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
生命科學工具市場規模預計到2023年為2,039.3億美元,到2024年達到2,261.4億美元,預計到2030年將達到4,291.9億美元,複合年成長率為11.21%。
生命科學是指研究生物的科學單位,例如生物學、植物學、動物學、微生物學、生理學和生物化學。生命科學研究使用各種設備、用品、試劑和其他服務。慢性病的全球流行要求改善疾病早期診斷的工具。有利的投資環境正在推動生命科學工具的使用,以加速生物技術的研究和開發,從而造福健康和醫療。然而,使用生命科學工具時的高成本以及品管問題可能會阻礙其在最終用途行業的採用。此外,基因組學和蛋白質組學在精準醫學中的日益成長的應用以及生命科學工具的突破性進展預計將推動生命科學工具在最終用途行業的部署。
主要市場統計 | |
---|---|
基準年[2023] | 2039.3億美元 |
預測年份 [2024] | 2261.4億美元 |
預測年份 [2030] | 4291.9億美元 |
複合年成長率(%) | 11.21% |
技術在細胞生物學技術中採用高解析度成像和單細胞分析工具
細胞生物學技術專注於研究細胞的生理特性、結構、細胞器、相互作用、生命週期、分裂和凋亡。這項研究需要癌症、遺傳疾病和藥物開發等領域的必要工具。在選擇細胞生物學工具時,研究人員優先考慮高通量篩檢、活細胞成像和單細胞分析功能。基因組技術涉及基因組的分析和操作。該領域的工具可以進行定序、基因型鑒定、基因表現分析等,以幫助了解疾病的遺傳基礎、個人化醫療和生物技術的進步。蛋白質體學技術涉及蛋白質體(生物體或系統產生的蛋白質的整個集合)及其功能的大規模研究。蛋白質體學技術是理解疾病機制、蛋白質交互作用和治療標靶的基礎。
最終用戶:醫院診斷和病患管理技術對生命科學工具的廣泛需求
學術研究機構優先考慮可負擔性、多功能性和最尖端科技來支援各種研究活動。他們的興趣範圍從基礎研究到應用科學,需要準確可靠的工具。與商業組織不同,學術研究機構通常在預算緊張的情況下運作,並專注於提供價值和多功能性的設備。生物技術公司致力於創新,需要尖端的生命科學工具來用於藥物發現、基因組學和蛋白質組學等研究和開發目的。合約研究和受託製造廠商(CRO/CMO) 優先考慮效率、擴充性和合規性,以支援其製藥和生物技術客戶的各種計劃。該細分市場與生技公司通用需要高通量和合規性設備,但不同之處在於強調服務的廣度,需要能夠適應不同客戶需求的工具。診斷實驗室重視診斷工具的準確性、可靠性和速度,以支援患者照護決策。用於大規模測試的自動化系統和用於患者資料的資料管理系統至關重要。醫院需要能夠無縫整合到患者照護工作流程中的生命科學工具。這包括診斷設備、病患監測工具、測試設備等可靠且易於臨床工作人員使用的設備。
區域洞察
生命科學工具市場以醫療和製藥領域為主,基因組學、蛋白質組學、腫瘤學和診斷篩檢的快速普及,主要企業不斷開發先進的生命科學研究工具,此後在南北發展。核准和使用基因組和組織診斷測試的有利法規環境正在推動美洲生命科學工具市場的成長。增加研發 (R&D) 支出以推進醫學研究,以及生物製藥公司更多地採用創新和先進工具,正在推動亞太地區生命科學工具的使用。歐洲、中東和非洲地區對醫療保健和製藥研發的投資增加、消費者對治療慢性病的先進醫療保健產品的支出增加以及政府對生命科學和製藥領域研發的支持預計將增加。持續的聯盟、收購和數位技術的採用預計將增加產量,並促進生命科學工具市場的全球成長。
FPNV定位矩陣
FPNV 定位矩陣對於評估生命科學工具市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對生命科學工具市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.生命科學工具市場的市場規模與預測是多少?
2.生命科學工具市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3.生命科學工具市場的技術趨勢和法規結構是什麼?
4.生命科學工具市場主要廠商的市場佔有率是多少?
5. 進入生命科學工具市場的合適型態和策略手段是什麼?
[184 Pages Report] The Life Science Tools Market size was estimated at USD 203.93 billion in 2023 and expected to reach USD 226.14 billion in 2024, at a CAGR 11.21% to reach USD 429.19 billion by 2030.
Life sciences refer to the unit of science that studies living organisms, including biology, botany, zoology, microbiology, physiology, and biochemistry. Various instruments, consumables, reagents, and other services are used to study life science. The prevalence of chronic diseases worldwide is raising the need for improved tools for the early diagnosis of diseases. The favorable investment landscape to accelerate R&D in the biotechnological sector for its implications in health and medicine facilitates using life science tools. However, the high cost of implementation and maintenance and the quality control issues associated with using life science tools may impede their adoption by the end-use industries. Moreover, the rising applications of genomics and proteomics for precision medicine and breakthrough advancements in life science tools are expected to encourage their deployment across the end-use industries.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 203.93 billion |
Estimated Year [2024] | USD 226.14 billion |
Forecast Year [2030] | USD 429.19 billion |
CAGR (%) | 11.21% |
Technology: Adoption of tools for higher-resolution imaging and single-cell analysis in cell biology technology
Cell biology technology focuses on studying cells' physiological properties, structure, organelles, interactions, life cycle, division, and apoptosis. This study requires tools essential for research in areas such as cancer, genetic diseases, and drug development. Researchers prioritize high-throughput screening, live cell imaging, and single-cell analysis capabilities when selecting cell biology tools. Genomic technology encompasses the analysis and manipulation of genomes. Tools in this segment enable sequencing, genotyping, gene expression analysis, and more, aiding in the understanding of genetic foundations of diseases, personalized medicine, and biotechnological advancements. Proteomics technology involves the large-scale study of proteomes (the entire set of proteins produced by an organism or system) and their functions. It is fundamental in understanding disease mechanisms, protein interactions, and therapeutic targets.
End-User: Broader requirement for life science tools in hospitals for diagnostics and patient management technologies
Academic research institutes prioritize affordability, versatility, and cutting-edge technology to support a variety of research activities. Their interests span basic research to applied science, necessitating tools that offer precision and reliability. Unlike commercial entities, academic institutes often operate under tighter budget constraints, focusing on equipment that offers both value and versatility. Biotechnology companies work on innovation, requiring state-of-the-art life science tools for R&D purposes, including drug discovery, genomics, and proteomics. Contract research/manufacturing organizations (CROs/CMOs) prioritize efficiency, scalability, and compliance as they handle diverse projects for pharmaceutical and biotech clients. This segment shares similarities with biotech companies regarding the need for high-throughput and compliance-ready equipment but differs in its focus on service breadth, requiring tools that are adaptable to varied client needs. Diagnostic labs emphasize accuracy, reliability, and speed in diagnostics tools to support patient care decisions. Automated systems for high-volume testing and data management systems for patient data are essential. Hospitals require life science tools that integrate seamlessly into patient care workflows. This includes diagnostic equipment, patient monitoring tools, and laboratory instruments that are reliable and easy to use for clinical staff.
Regional Insights
The life science tools market is evolving in the Americas owing to the highly valued medical and pharmaceutical sector, rapid adoption of genomics, proteomics, oncology, and diagnostic screening, and major players continuously developing advanced tools for life science research. A well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is encouraging the life science tools market growth in the Americas. Increasing research and development (R&D) expenditure to advance medical research and the growing adoption of innovative and advanced tools among biopharmaceutical companies are facilitating the use of life science tools in the APAC region. Rising investments in research and development of healthcare and pharmaceutical products, growing consumer expenditure on advanced healthcare products to treat chronic diseases, and supportive government initiatives for life science and pharmaceutical sector development are expanding the utilization of life science tools in the EMEA region. The ongoing collaborations, acquisitions, and embracing of digital technologies can increase production and are expected to contribute to the growth of the life science tools market worldwide.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Life Science Tools Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Life Science Tools Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux SA, Bruker Corporation, Cardinal Health, Inc., Carl Zeiss AG, Charles River Laboratories International, Inc., Danaher Corporation, Diagnostica Longwood S.L., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., GE Healthcare Technologies Inc., Genscript Biotech Corporation, Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Illumina, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., Luminex Corporation, Merck KGaA, Mettler-Toledo International Inc., New England Biolabs, Inc., Oxford Instruments PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics Incorporated, Repligen Corporation, Sartorius AG, SGS SA, Shimadzu Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Life Science Tools Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Life Science Tools Market?
3. What are the technology trends and regulatory frameworks in the Life Science Tools Market?
4. What is the market share of the leading vendors in the Life Science Tools Market?
5. Which modes and strategic moves are suitable for entering the Life Science Tools Market?
TABLE 341